Psychalgia News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psychalgia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Psychalgia Today - Breaking & Trending Today
email article On the heels of the cannabidiol (CBD) craze come three other cannabinoids touted as potential treatments for various medical issues: cannabigerol (CBG), cannabinol (CBN), and delta-8 THC (tetrahydrocannabinol). While companies are freely selling products featuring these compounds, especially delta-8, practitioners and industry insiders note little evidence exists regarding any of the three. They especially question delta-8, which has captivated the market over the last year despite a dearth of research. Given the nature of these compounds (on their own), it s unlikely that they re unsafe, Jordan Tishler, MD, president of the Association of Cannabis Specialists, wrote in an email to ....
There s some room for improvement in diagnosing pediatric hidradenitis suppurativa (HS), researchers suggested. In an international cross-sectional analysis of 481 patients diagnosed with HS, the average age of diagnosis came about 2 years after the average age of disease onset (14.4 and 12.5 years, respectively), according to Irene Lara-Corrales, MD, of the University of Toronto, and colleagues. Among adolescents, the inflammatory skin condition most often presented with a cyst or abscess, accounting for about half of the first signs and symptoms, they stated in The second and third most common initial symptoms of the debilitating disorder were pain and tenderness (25%), followed by papules and pustules (24%). ....
email article Ten companies were called out by the FDA for illegally selling supplements claiming to cure depression and other mental health disorders. A survey of 381 patients recovered from COVID-19 found that more than 30% had post-traumatic stress disorder. ( JAMA Psychiatry) Intra-Cellular Therapies is formally seeking two new indications for its bipolar medication lumateperone (Caplyta) as monotherapy and as adjunctive therapy to lithium or valproate for depressive episodes of adult bipolar I or II disorder. A meta-analysis of 12 studies and nearly two million participants found that childhood attention-deficit/hyperactivity disorder was tied to an increased risk for developing a psychotic disorder. ( ....
email article A history of either anxiety or depression was inversely associated with the age when Alzheimer s disease started, a retrospective analysis suggested. People with Alzheimer s disease who had a past diagnosis of anxiety were 3 years younger than other Alzheimer s patients when they developed the disease, reported Zachary Miller, MD, of the University of California San Francisco (UCSF), and co-authors. Patients with a history of depression were 2 years younger at Alzheimer s onset, they said in an abstract released in advance of the 2021 American Academy of Neurology annual meeting. The findings were based on 1,500 Alzheimer s disease patients from the UCSF Memory and Aging Center who were screened for past psychiatric disorders, including depression, anxiety, bipolar disorder, schizophrenia, and post-traumatic stress disorder (PTSD). Researchers evaluated typical Alzheimer s risk factors hypertension, hyperlipidemia, diabetes, education, and ....
email article Healthcare providers have aggressively climbed onto the virtual care bandwagon since last March, conducting half or more of their patient visits by phone or computer. From mid-March to mid-October, nearly 40% of Medicare beneficiaries received a covered telemedicine service. Now, with barely a year s worth of experience and few studies to rate outcomes, researchers are asking if virtual care standards whatever they are and patient access to telehealth platforms are good enough. The question will be particularly relevant if payers continue reimbursing at in-person visit rates after the pandemic subsides, as the Centers for Medicare & Medicaid Services (CMS) said it was considering in August. ....